Triple antiplatelet tx increases bleeding and no better than standard therapy for preventing TIA and recurrent CVA (TARDIS)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Triple Antiplatelet Tx Increases Bleeding and No Better Than Standard Therapy for Preventing TIA and Recurrent CVA (TARDIS)." EE+ POEM Archive, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314504/all/Triple_antiplatelet_tx_increases_bleeding_and_no_better_than_standard_therapy_for_preventing_TIA_and_recurrent_CVA__TARDIS_.
Triple antiplatelet tx increases bleeding and no better than standard therapy for preventing TIA and recurrent CVA (TARDIS). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314504/all/Triple_antiplatelet_tx_increases_bleeding_and_no_better_than_standard_therapy_for_preventing_TIA_and_recurrent_CVA__TARDIS_. Accessed March 23, 2025.
Triple antiplatelet tx increases bleeding and no better than standard therapy for preventing TIA and recurrent CVA (TARDIS). (2025). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314504/all/Triple_antiplatelet_tx_increases_bleeding_and_no_better_than_standard_therapy_for_preventing_TIA_and_recurrent_CVA__TARDIS_
Triple Antiplatelet Tx Increases Bleeding and No Better Than Standard Therapy for Preventing TIA and Recurrent CVA (TARDIS) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2025. [cited 2025 March 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314504/all/Triple_antiplatelet_tx_increases_bleeding_and_no_better_than_standard_therapy_for_preventing_TIA_and_recurrent_CVA__TARDIS_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Triple antiplatelet tx increases bleeding and no better than standard therapy for preventing TIA and recurrent CVA (TARDIS)
ID - 1314504
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314504/all/Triple_antiplatelet_tx_increases_bleeding_and_no_better_than_standard_therapy_for_preventing_TIA_and_recurrent_CVA__TARDIS_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -